Abstract:! Some! 5(aryl(triazolo[4, 3<a] ! hexahydro! quinazoline! derivatives! (4aJ4e! &! 5aJ5e)! were! synthesized! and! evaluated! for! their! in! vitro! antiglycation! and! antioxidant! activities.! Title! compounds! were! found! to! have! potent! antiglycating! activity! than! rutin! in! the! range! between! 0.096! and! 0.300! µM.The! compounds! 4b! and! 5c! were! the! most! active! ones! among! them.! The! tested! compounds! had! shown!potent!to!moderate!antioxidant!activity!by!DPPH! assay! than! BHT! except! 5e! (p<NO2! phenyl! derivative).! Among! all,! hydroxyl! derivatives! (4aJ4e)! are! more! potent!than!the!corresponding!thiols!(5aJ5e).!
The! incidence! of! type(2! diabetes! is! increasing! at! an! alarming!rate!and!about!1-2%!of!the!world's!population! is! affected! with! over! 100! million! diabetic! patients! worldwide.! Diabetes! is! a! multi(factorial! disease! with! associated! complications.! However,! exact! molecular! basis!of!these!complications!is!not!fully!understood!yet.! Hyperglycemia! is! one! of! the! contributing! factors! of! these! complications! i.e.! atheroma,! hypertension! and! microangiopathy,! mostly! attributed! to! the! formation! of! sugar(derived!substances!called!advanced!glycation!end! products!(AGEPs)! 1 .!A!vast!number!of!evidences!suggest! that!AGEPs!are!important!physio(pathogenic!mediators! of!almost!all!diabetic!complications! 2 .!AGEPs!are!a!group! of!molecules!formed!in!a!non(enzymatic!glycation!from! combination!of!reducing!sugars!with!free!amino!groups! of! proteins,! lipids,! enzymes,! phospholipids! and! nucleic! acids.!! Initial!product!of!amino!group!of!protein!with!carbonyl! group! of! glucose! interaction,! is! a! Schiff! base,! whereas! the! rearrangement! of! Schiff! base! intermediate! to! Amadori! product! takes! number! of! days.! An! Amadori! product! undergoes! subsequent! oxidative! modifications! (glycoxidations)! that! are! induced! by! reactive! oxygen! species!(ROS)!and!reactive!nitrogen!species!(RNS).!The! end! result! of! these! complex! series! of! reactions! is! the! formation! of! AGEs.! Extent! of! glycation! of! vital! biochemicals! is! dependent! on! the! degree! and! duration! of! hyperglycemia! in! vivo.! Considerable! effort! has! been! focused!on!the!discovery!of!new!inhibitors!of!glycation! because!of!their!therapeutic!potential! 3 .! The!antiglycating!agents!may!react!with!carbonyl!group! of! reducing! sugars,! Amadori! products! and! 3( deoxyglucosones! to! prevent! AGEPs! formation.! Certain! agents! have! been! established! that! can! cleave! AGEP! cross(links! and! perhaps! open! the! possibility! of! moving! back! the! steady! process! of! diabetic! complications! 4 .! Antioxidants!may!offer!protection!against!glycated!free! radicals,! while! chelators! are! helpful! in! removing! the! transition! metals! to! prevent! glycoxidations! (auto! oxidation)!of!glucose!and!Amadori!products! 5,!6 .! Compounds! with! both! antiglycation! and! antioxidant! properties! may! offer! therapeutic! potential.! It! has! been! found! that! aged! garlic! extract! (AGE)! inhibit! the! formation! of! AGEPs! in! vitro! and! it! also! prevents! the! formation! of! glycation(derived! free! radicals.S(Allyl( cysteine! is! a! key! component! of! aged! garlic! extract! that! acts!as!a!potent!antioxidant!and!may!inhibit!the!AGEPs! formation 7 .! Aminoguanidine! (inhibitor! of! AGEP! formation)!was!found!to!prevent!retinopathy!in!diabetic! animals!and!has!been!withdrawn!from!phase!III!clinical! trials!due!to!its!toxicity,!hence!can!serve!as!a!prototype! for! novel! molecules! that! are! being! synthesized! and! evaluated!in!vitro 8,!9 .! Quinazoline!and!its!derivatives!constitute!an!interesting! molecule! among! the! most! important! classes! of! an! hetero!aromatic!bicyclic!compounds!with!!wide(ranging!! biological! and! pharmacological! ! activities! ! such!! analgesic 10 ,! anticancer 11 ,! anticonvulsant 12 ,! anti(HIV 13 (4,5,6,7,8,9(hexahydro( [1,2,4] triazolo [4,3<a] (4,5,6,7,8,9(hexahydro( [1,2,4] triazolo [4,3<a] Table! 3,4,5,6,7,8<hexahydroquinazolin<2(1H) < 4,5,6,7,8,9<hexahydro<[1,2,4] triazolo [4,3<a] 
3.1.2.! General! procedure! for! synthesis! of! 4<aryl<

quinazolin<1< ol!(4a#4e):!
A! mixture! of! 4(aryl (3,4,5,6,7,8(hexahydroquinazolin( 2(1H) < 4,5,6,7,8,9<hexahydro<[1,2,4] triazolo [4,3<a] 
3.1.4.! General! procedure! for! synthesis! of! 5<(4<aryl)
<quinazolin<1< thiol!(5a#5e):!
A! mixture! of! 4(aryl (3,4,5,6,7,8(hexahydroquinazolin( 2(1H) 5,6,7,8,9<hexahydro[1,2,4] triazolo [4,3< a] <4,5,6,7,8,9<hexahydro<! [1,2,4] ! triazolo! [4,3<a] <4,5,6,7,8,9< hexahydro[1,2,4] triazolo [4,3! <a] <4,5,6,7,8,9<hexahydro[1,2,4] triazolo [4,3< a] <4,5,6,7,8,9< hexahydro[1,2,4] triazolo [4,3<a] 5<phenyl<4,5,6,7,8,9<hexahydro[1,2,4] triazolo [4,3< a] <4,5,6,7,8,9< hexahydro[1,2,4] triazolo [4,3<a] <4,5,6,7,8,9< hexahydro[1,2,4] triazolo [4,3<a] <4,5,6,7,8,9<hexahydro[1,2,4] triazolo [4,3< a] <4,5,6,7,8,9< hexahydro[1,2,4] triazolo [4,3<a] Spectrophotometer.! Methanol! (1! ml)! with! DPPH! solution! (1! ml)! was! used! as! blank.! The! optical! density! was!recorded!and!%!inhibition!was!calculated!using!the! formula!given!below 34 :! %"Inhibition"of"DPPH"activity"=" [A 0 6A s ]
A 0 x"100 ! Where! A0! is! the! absorbance! of! control! and! As! is! the! absorbance!of!sample.!
4.!Conclusion!
Advanced!glycation!end!products!are!the!main!cause!for! diabetic! complications.! Aminoguanidine! is! the! prototype! molecule! for! use! in! the! treatment! of! these! complications! like! retinopathy.! In! the! present! study,! triazolo(! hexahydroquinazolines! were! synthesized! as! isosteric! modification! of! the! aminoguanidines! and! evaluated! them! for! antiglycating! and! antioxidant! activities.!The!molecules!4b!and!5c!were!found!to!have! potent! antiglycating! activity! than! rutin! and! less! potent! than! glibenclamide! due! to! the! presence! of! electron! donating! groups! substituted! on! the! benzene! ring.! The! molecules! 4b! and! 4c! were! found! to! have! potent! antioxidant! activity! due! to! the! presence! of! hydroxyl! groups.! The! results! obtained! may! contribute! to! the! development!of!an!ideal!antiglycating!agents.!
